Share Price:

APNASPENAspen Pharmacare Hldgs1084997 (0.90%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen announces multi-territory acquisition of GSK OTC products for R2.1 billion

Aspen Pharmacare Holdings Limited (β€œAspen”) (Incorporated in the Republic of South Africa) Registration Number 1985/002935/06 Share code APN – ISIN: ZAE000066692 (β€œAspen Holdings”) ASPEN ANNOUNCES MULTI-TERRITORY ACQUISITION OF GSK OTC PRODUCTS FOR R2.1 BILLION Durban, South Africa: Aspen Holdings is pleased to announce that the Aspen Group (β€œAspen”) has reached agreement with GlaxoSmithKline plc (β€œGSK”)… Continue reading Aspen announces multi-territory acquisition of GSK OTC products for R2.1 billion

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: